<DOC>
	<DOCNO>NCT01527786</DOCNO>
	<brief_summary>Postpartum depress woman suffer functional impairment mood , thought , cognition physical well lead poor motivation , bond difficulty , decreased productivity , conflict neglect . Moderate/ severe depression respond best combination antidepressant counsel . This study estimate proportion woman return functionality treatment Desvenlafaxine examine differential impact change depression anxiety symptom functionality twelve week . Depression anxiety symptom monitor six mood questionnaire ; functional recovery monitor simple self-report questionnaire visit .</brief_summary>
	<brief_title>Functional Outcome Postpartum Depression Women Treated With Desvenlafaxine</brief_title>
	<detailed_description>Women recruit tertiary level care program advertisement BC Children 's &amp; Women 's Hospital well St.Paul 's Hospital , Vancouver , B.C. , Canada . If deem eligible study ( meet diagnosis postpartum depression without comorbid anxiety disorder ) potential participant agree participate , consent sign . The participant return bi-weekly basis study visit , mood anxiety monitor , addition blood pressure weight . Starting dose Desvenlafaxine 50mg , titrate 100mg/per day need . Questionnaires assess depression symptom , anxiety symptom , quality life , panic disorder , obsessive-compulsive disorder generalize anxiety disorder .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>1 . To able read write English . 2 . Written inform consent initiation study related procedure . 3 . Diagnosis Major Depressive Disorder ( MDD ) onset depressive symptom within 12 month delivery . 4 . Diagnosis additional comorbid panic , generalize anxiety obsessive compulsive disorder , occur addition MDD . 5 . Patients require score ( great equal ) 25 MontgomeryAsberg Depression Rating Scale ( MADRS ) enrolment ( moderate severe depression ) . 6 . Patients need refer usual treating primary care physician . 7 . Those referral must meet clinic criterion accept referral potential participant eligible receive treatment clinic per usual clinical practice . 8 . Patient wish pursue CBT elsewhere . 9 . The patient use appropriate method contraception , may include abstinence , order avoid pregnancy study . 10 . The patient currently breastfeed . 1 . The patient currently breastfeed pregnant . 2 . The patient significant risk suicide accord investigator 's opinion present score Â³5 item 10 ( suicidal thought ) MADRS . 3 . The patient meet DSMIVTR criterion : current Posttraumatic Stress Disorder , past current manic hypomanic episode , past current psychotic symptom disorder , current drug alcohol abuse dependence , current eat disorder ( anorexia bulimia ) . 4 . The patient us follow disallow recent concomitant medication within specified time period : antidepressant drug use augmentation antidepressant action within last 1 week 3 week fluoxetine ( longer half life ) prior baseline . Subject 's mood monitor . hypnotic within last week prior baseline oral antipsychotic within 2 week depot antipsychotic within 6 month prior baseline . serotonergic medicinal product ( example , triptans , tryptophan , tramadol ) within last week prior baseline . Psychoactive herbal remedy ( example , St. Johns Wort , kava kava , valerian , ginkgo biloba ) within last 2 week prior baseline . drug potential psychotropic effect within last 2 week prior baseline . anticonvulsant drug within last 2 week prior baseline . investigational product within 3 month prior baseline . 5 . The patient currently receive formal cognitive behavioural therapy , systematic psychotherapy elsewhere , plan initiate therapy study outside clinic . 6 . The current depressive symptom patient consider investigator resistant two wellconducted antidepressant treatment least 6 week duration . 7 . The patient serious illness serious sequela thereof , include liver renal insufficiency , cardiovascular , pulmonary , gastrointestinal , endocrine , neurological ( include epilepsy ) , infectious , neoplastic , metabolic disturbance . ( If history disease condition stable least one year judge investigator render inclusion unsafe interfere patient 's participation study , patient may include ) .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Major Depressive Disorder , Postpartum Onset</keyword>
</DOC>